Fear of cancer recurrence and associated factors in family caregivers of patients with hematologic malignancy receiving chemotherapy: A latent profile analysis.

Li Sheng, Yingying Zhu, Yajiao Liu, Haiying Hua, Jingfen Zhou, Long Ye
Author Information
  1. Li Sheng: Wuxi School of Medicine, Jiangnan University, Wuxi, China.
  2. Yingying Zhu: Wuxi School of Medicine, Jiangnan University, Wuxi, China.
  3. Yajiao Liu: Nursing Department, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  4. Haiying Hua: Wuxi School of Medicine, Jiangnan University, Wuxi, China.
  5. Jingfen Zhou: Department of Hematology, Affiliated Hospital of Jiangnan University, Wuxi, China.
  6. Long Ye: Department of Hematology, Affiliated Hospital of Jiangnan University, Wuxi, China.

Abstract

Objective: This study identified the potential subgroups of fear of cancer recurrence (FCR) in family caregivers (FCs) of patients with hematologic malignancies receiving chemotherapy, as well as exploring factors associated with subgroups.
Methods: This was a cross-sectional study involving 206 pairs of participating patients with hematologic malignancies receiving chemotherapy and their FCs. Using Mplus 8.3 to perform the latent profile analysis of FCs' FCR, the FCs' burden, quality of life, psychological resilience, and anxiety as well as their demographic characteristics were compared between the subgroups, with a logistic regression analysis being applied to examine the factors associated with the FCR subgroups.
Results: A total of 206 FCs were classified into two subgroups: "a low level of FCR" (Class 1, 65.4%) and "a high level of FCR" (Class 2, 34.6%). Quality of life, anxiety, and frequency of chemotherapy were significantly associated with the two subgroups.
Conclusions: FCs of patients with hematologic malignancy receiving chemotherapy had two FCR subgroups, "a low level of FCR" and "a high level of FCR", in association with quality of life, anxiety, and frequency of chemotherapy. These findings provide the theoretical foundations for screening the FCR factor of FCs and conducting interventions for them.

Keywords

References

  1. Scand J Caring Sci. 2020 Jun;34(2):340-347 [PMID: 31250939]
  2. PLoS One. 2023 Mar 13;18(3):e0282887 [PMID: 36913399]
  3. Scand J Caring Sci. 2020 Dec;34(4):889-898 [PMID: 31750576]
  4. Psychooncology. 2020 Feb;29(2):364-372 [PMID: 31654534]
  5. Eur J Oncol Nurs. 2018 Dec;37:1-11 [PMID: 30473044]
  6. Int J Environ Res Public Health. 2022 Oct 12;19(20): [PMID: 36293701]
  7. Psychooncology. 2017 Dec;26(12):2079-2085 [PMID: 28317267]
  8. J Pain Symptom Manage. 2011 Sep;42(3):432-42 [PMID: 21477979]
  9. J Hematol Oncol. 2023 Jun 23;16(1):65 [PMID: 37353849]
  10. J Clin Oncol. 2020 Mar 20;38(9):926-936 [PMID: 32023152]
  11. BMC Palliat Care. 2020 Jun 3;19(1):77 [PMID: 32493301]
  12. Support Care Cancer. 2015 Aug;23(8):2383-9 [PMID: 25591628]
  13. Health Psychol. 2018 Sep;37(9):874-884 [PMID: 30138023]
  14. Cancer Nurs. 2022 Mar-Apr 01;45(2):E454-E462 [PMID: 34120129]
  15. Psychooncology. 2013 Jul;22(7):1557-64 [PMID: 22941765]
  16. Support Care Cancer. 2023 Jan 4;31(1):95 [PMID: 36598590]
  17. Arch Intern Med. 2006 May 22;166(10):1092-7 [PMID: 16717171]
  18. Ann Behav Med. 2022 Nov 5;56(11):1131-1143 [PMID: 35551585]
  19. J Cancer Surviv. 2022 Aug;16(4):823-833 [PMID: 34302272]
  20. Support Care Cancer. 2022 Jan;30(1):825-833 [PMID: 34389907]
  21. Psychooncology. 2019 Jun;28(6):1301-1307 [PMID: 30946501]
  22. Am J Hosp Palliat Care. 2020 Aug;37(8):648-658 [PMID: 31830813]
  23. J Clin Nurs. 2018 Dec;27(23-24):4321-4330 [PMID: 29964322]
  24. Psychooncology. 2018 Jun;27(6):1580-1588 [PMID: 29508471]
  25. J Psychosoc Oncol. 2015;33(3):250-62 [PMID: 25758128]
  26. Support Care Cancer. 2022 Aug;30(8):6923-6935 [PMID: 35543814]
  27. Support Care Cancer. 2020 Dec;28(12):5973-5982 [PMID: 32285261]
  28. Eur J Oncol Nurs. 2013 Dec;17(6):760-6 [PMID: 23615709]
  29. J Cancer Surviv. 2016 Oct;10(5):802-13 [PMID: 26899851]
  30. J Clin Oncol. 2007 Oct 20;25(30):4829-34 [PMID: 17947732]
  31. Ann Behav Med. 2003 Winter;25(1):16-24 [PMID: 12581932]
  32. Int J Nurs Stud. 2022 Mar;127:104179 [PMID: 35124473]
  33. Nurs Res. 2017 Jul/Aug;66(4):295-303 [PMID: 28654567]
  34. Eur J Oncol Nurs. 2016 Feb;20:97-105 [PMID: 26187660]
  35. Curr Opin Support Palliat Care. 2019 Sep;13(3):238-242 [PMID: 31157656]
  36. Psychooncology. 2016 Jun;25(6):663-9 [PMID: 26387642]
  37. Psychooncology. 2017 Jan;26(1):22-28 [PMID: 26490953]
  38. Asia Pac J Oncol Nurs. 2021 Jan 29;8(2):204-210 [PMID: 33688570]
  39. Support Care Cancer. 2016 Nov;24(11):4669-78 [PMID: 27378380]
  40. Front Psychol. 2023 Mar 28;14:1059605 [PMID: 37057172]
  41. Signal Transduct Target Ther. 2023 Feb 17;8(1):71 [PMID: 36797244]
  42. Psychol Methods. 2017 Sep;22(3):563-580 [PMID: 27607543]
  43. J Nurs Res. 2016 Sep;24(3):240-8 [PMID: 27509212]
  44. CA Cancer J Clin. 2023 Jan;73(1):17-48 [PMID: 36633525]
  45. Front Psychol. 2021 Jul 16;12:625654 [PMID: 34335354]
  46. J Intellect Disabil. 2013 Mar;17(1):24-37 [PMID: 23334231]
  47. Psychooncology. 2021 Feb;30(2):176-184 [PMID: 32931646]
  48. Ann Behav Med. 2021 Mar 20;55(3):192-202 [PMID: 32608472]
  49. Psychiatry Clin Neurosci. 2010 Oct;64(5):499-504 [PMID: 20923429]
  50. Gerontologist. 1986 Jun;26(3):260-6 [PMID: 3721233]
  51. Am J Hosp Palliat Care. 2020 Apr;37(4):305-313 [PMID: 31550902]
  52. Psychooncology. 2009 Aug;18(8):841-8 [PMID: 19101920]
  53. Support Care Cancer. 2009 Mar;17(3):241-51 [PMID: 18414902]
  54. J Cardiovasc Nurs. 2011 Jan-Feb;26(1):53-64 [PMID: 21127427]
  55. Front Digit Health. 2023 Aug 21;5:1129536 [PMID: 37671170]

Word Cloud

Created with Highcharts 10.0.0subgroupsFCRFCschemotherapypatientshematologicreceivingassociatedanalysis"alevelFCR"cancerrecurrencecaregiversfactorsprofilelifeanxietytwomalignancystudyfamilymalignancieswell206latentFCs'qualitylowClasshighfrequencyFearObjective:identifiedpotentialfearexploringMethods:cross-sectionalinvolvingpairsparticipatingUsingMplus83performburdenpsychologicalresiliencedemographiccharacteristicscomparedlogisticregressionappliedexamineResults:totalclassifiedsubgroups:1654%2346%QualitysignificantlyConclusions:associationfindingsprovidetheoreticalfoundationsscreeningfactorconductinginterventionsthemchemotherapy:ChemotherapyFamilyHematologicLatent

Similar Articles

Cited By